Cyclerion Therapeutics, Inc. Uncategorized Contracts & Agreements

14 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Amendment to Original Offer Letter Regina Graul
Cyclerion Therapeutics, Inc.
Biotechnology
2024
Offer Letter to Regina Graul dated December 1, 2023
Cyclerion Therapeutics, Inc.
Biotechnology
2024
Offer Letter, effective April 1, 2019, by and between Cyclerion Therapeutics, Inc. and Anjeza Gjino
Cyclerion Therapeutics, Inc.
Biotechnology
2024
Description of Securities Registered pursuant to Section 12 of the Securities Exchange Act of 1934, as amended
Cyclerion Therapeutics, Inc.
Biotechnology
2024
Offer Letter, effective April 1, 2019, by and between Cyclerion Therapeutics, Inc. and Cheryl Gault
Cyclerion Therapeutics, Inc.
Biotechnology
2022
Description of Securities Registered pursuant to Section 12 of the Securities Exchange Act of 1934, as amended
Cyclerion Therapeutics, Inc.
Biotechnology
2022
Description of Securities Registered pursuant to Section 12 of the Securities Exchange Act of 1934, as amended
Cyclerion Therapeutics, Inc.
Biotechnology
2021
Open Market Sale AgreementSM, dated September 3, 2020, by and between Cyclerion Therapeutics, Inc. and Jefferies LLC
Cyclerion Therapeutics, Inc.
Biotechnology
NY
2020
Description of Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934, as amended
Cyclerion Therapeutics, Inc.
Biotechnology
2020
Offer Letter, effective April 1, 2019, by and between Cyclerion Therapeutics, Inc. and William Huyett
Cyclerion Therapeutics, Inc.
Biotechnology
2019
Offer Letter, effective April 1, 2019, by and between Cyclerion Therapeutics, Inc. and Mark G. Currie, Ph.D
Cyclerion Therapeutics, Inc.
Biotechnology
2019
Offer Letter, effective April 1, 2019, by and between Cyclerion Therapeutics, Inc. and Peter M. Hecht, Ph.D
Cyclerion Therapeutics, Inc.
Biotechnology
2019
Employee Matters Agreement, dated as of March 30, 2019, by and between Ironwood Pharmaceuticals, Inc. and Cyclerion Therapeutics, Inc
Cyclerion Therapeutics, Inc.
Biotechnology
MA
2019
Tax Matters Agreement, dated as of March 30, 2019, by and between Ironwood Pharmaceuticals, Inc. and Cyclerion Therapeutics, Inc
Cyclerion Therapeutics, Inc.
Biotechnology
DE
2019